S 2160

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596870

CAS#: 54799-93-8

Description: S 2160 is a synthetic chromogenic substrate for thrombin; liberates p-nitroaniline.

Chemical Structure

S 2160
CAS# 54799-93-8

Theoretical Analysis

MedKoo Cat#: 596870
Name: S 2160
CAS#: 54799-93-8
Chemical Formula: C33H40N8O6
Exact Mass: 644.3071
Molecular Weight: 644.73
Elemental Analysis: C, 61.48; H, 6.25; N, 17.38; O, 14.89

Price and Availability

Size Price Availability Quantity
5.0mg USD 340.0 2 Weeks
10.0mg USD 570.0 2 Weeks
50.0mg USD 1430.0 2 Weeks
Bulk inquiry

Synonym: S 2160; S-2160; S2160; Bzphevalargnan; Bz-Phe-val-arg-paranitroanilide;

IUPAC/Chemical Name: N-((S)-1-(((S)-1-(((S)-1-amino-5-guanidino-1-oxopentan-2-yl)(4-nitrophenyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzamide


InChi Code: InChI=1S/C33H40N8O6/c1-21(2)28(39-31(44)26(20-22-10-5-3-6-11-22)38-30(43)23-12-7-4-8-13-23)32(45)40(24-15-17-25(18-16-24)41(46)47)27(29(34)42)14-9-19-37-33(35)36/h3-8,10-13,15-18,21,26-28H,9,14,19-20H2,1-2H3,(H2,34,42)(H,38,43)(H,39,44)(H4,35,36,37)/t26-,27-,28-/m0/s1

SMILES Code: N=C(N)NCCC[C@@H](C(N)=O)N(C([C@H](C(C)C)NC([C@H](CC1=CC=CC=C1)NC(C2=CC=CC=C2)=O)=O)=O)C3=CC=C([N+]([O-])=O)C=C3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 644.73 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Balasubramanian N, Toubarro D, Simões N. Biochemical study and in vitro insect immune suppression by a trypsin-like secreted protease from the nematode Steinernema carpocapsae. Parasite Immunol. 2010 Mar;32(3):165-75. doi: 10.1111/j.1365-3024.2009.01172.x. PubMed PMID: 20398179.

2: Jiao HM, Yang LX, Lu B, Wu YQ, Zhou YC. Shedaoenase, a novel fibrinogenase from the venom of Agkistrodon shedaoenthesis Zhao. Acta Biochim Biophys Sin (Shanghai). 2005 Dec;37(12):835-42. PubMed PMID: 16331328.

3: Rosén S. Chromogenic methods in coagulation diagnostics. Hamostaseologie. 2005 Aug;25(3):259-66. Review. PubMed PMID: 16113749.

4: Johns ME, Tai PC, Derby CD. Serine proteases in the spiny lobster olfactory organ: their functional expression along a developmental axis, and the contribution of a CUB-serine protease. J Neurobiol. 2004 Dec;61(3):377-91. PubMed PMID: 15389692.

5: Kolodzeĭskaia MV, Chernyshenko TM. [Human thrombin: enzymatic properties, stability and standardization of preparation]. Ukr Biokhim Zh (1999). 2002 Sep-Oct;74(5):27-33. Russian. PubMed PMID: 12916152.

6: Rozs M, Manczinger L, Vágvölgyi C, Kevei F. Secretion of a trypsin-like thiol protease by a new keratinolytic strain of Bacillus licheniformis. FEMS Microbiol Lett. 2001 Dec 18;205(2):221-4. PubMed PMID: 11750806.

7: Ring PC, Wan H, Schou C, Kroll Kristensen A, Roepstorff P, Robinson C. The 18-kDa form of cat allergen Felis domesticus 1 (Fel d 1) is associated with gelatin- and fibronectin-degrading activity. Clin Exp Allergy. 2000 Aug;30(8):1085-96. PubMed PMID: 10931115.

8: Ashizawa K, Hashimoto K, Suzuki Y, Tsuzuki Y. Inhibition of flagellar motility of demembranated fowl spermatozoa by protease substrates. Comp Biochem Physiol B Biochem Mol Biol. 1998 Sep;121(1):77-83. PubMed PMID: 9972285.

9: Williams AG, Coombs GH. Multiple protease activities in Giardia intestinalis trophozoites. Int J Parasitol. 1995 Jul;25(7):771-8. PubMed PMID: 7558562.

10: SinhaRoy M, Bharadwaj D, Hati RN. Chymotrypsinogen: an activating enzyme in the mitochondrial membrane of rat submaxillary gland. Biochem Int. 1991 Dec;25(6):1035-41. PubMed PMID: 1725694.

11: Komori Y, Hagihara S, Tu AT. Specificity of hemorrhagic proteinase from Crotalus atrox (western diamondback rattlesnake) venom. Biochim Biophys Acta. 1985 May 20;829(1):127-30. PubMed PMID: 3888273.

12: Musci G, Metz GD, Tsunematsu H, Berliner LJ. 4,4'-Bis[8-(phenylamino)naphthalene-1-sulfonate] binding to human thrombins: a sensitive exo site fluorescent affinity probe. Biochemistry. 1985 Apr 9;24(8):2034-9. PubMed PMID: 4016098.

13: Torano AE, Nakamura S, Levin J. Properties of the clotting enzyme responsible for endotoxin-mediated Limulus coagulation. Thromb Res. 1984 Jun 1;34(5):407-17. PubMed PMID: 6377572.

14: Baskova IP, Paskhina TS, Poliantseva LR, Iakubovskaia RI, Tiero A. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome]. Vopr Med Khim. 1983 Sep-Oct;29(5):96-9. Russian. PubMed PMID: 6557709.

15: Yomtova VM, Stambolieva NA, Blagoev BM. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase. Thromb Haemost. 1983 Jun 28;49(3):199-203. PubMed PMID: 6224310.

16: Mackie IJ, Seghatchian MJ. Analysis of the procoagulant activities of factor IX concentrates. Thromb Res. 1982 Nov 15;28(4):499-507. PubMed PMID: 6819651.

17: Rodgers GM, Donaldson VH, Shuman MA. Radioisotopic measurement of plasma kallikrein. Thromb Res. 1982 Sep 15;27(6):641-9. PubMed PMID: 6924801.

18: Abildgaard U. Methodological considerations on antithrombin determination. Acta Chir Scand Suppl. 1982;509:97-9. PubMed PMID: 6962626.

19: Orthner CL, Morris S, Kosow DP. Inhibition of human coagulation factor Xa by thrombin substrates. Thromb Res. 1981 Sep 15;23(6):533-9. PubMed PMID: 7324010.

20: Smith GF, Sundboom JL. Heparin and protease inhibition. II. The role of heparin in the ATIII inactivation of thrombin, plasmin, and trypsin. Thromb Res. 1981 Apr 1-15;22(1-2):115-33. PubMed PMID: 6457414.

S 2160

5.0mg / USD 340.0